NBIX vs TCRT · P/E 45, rev $1.77B vs $5.6M cap
Neurocrine Biosciences Inc (NBIX) versus Alaunos Therapeutics Inc (TCRT) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. TCRT currently screens at market cap $5.6M.
Not investment advice. Open the NBIX and TCRT stock pages for the full models.
Not investment advice.